Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes

Journal of Neuroscience Research

Volumn 87, Issue 1, 2009, Pages 218-227

  Rawal, Seema ^a   Morisseau, Christophe ^b   Hammock, Bruce D ^b   Shivachar, Amruthesh C ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrocytes; GFAP; Glial fibrillary acidic protein; Microsomal epoxide hydrolase; Soluble epoxide hydrolase

Indexed keywords

EPOXIDE HYDROLASE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN FUNCTION; CELL FRACTIONATION; CELL LYSATE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME SPECIFICITY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; MICROSOME; MOLECULAR WEIGHT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOMETRY; RAT; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; EPOXIDE HYDROLASES; GLIAL FIBRILLARY ACIDIC PROTEIN; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS;

EID: 63049107658     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21827     Document Type: Article

References (38)

1. Amruthesh SC, Boerschel MF, Mckinney JS, Willoughby KA, Ellis EF. 1993. Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes. J Neurochem 61:150-159.
2. Arand M, Cronin A, Adamska M, Oesch F. 2005. Epoxide hydrolases: structure, function, mechanism, and assay. Methods Enzymol 400:569-588.
3. Borhan B, Mebrahtu T, Nazarian S, Kurth MJ, Hammock BD. 1995. Improved radiolabeled substrates for soluble epoxide hydrolase. Anal Biochem 231:188-200.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Capdevila JH, Falck JR, Harris RC. 2000. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 41:163-181.
6. Chacos N, Capdevila JH, Falck JR, Manna S, Martin-Wixtrom C, Gill SS, Hammock BD, Estabrook RW. 1983. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with cytosolic epoxide hydrolase. Arch Biochem Biophys 233:639-648.
7. DiBiasio KW, Silva MH, Shull LR, Overstreet JW, Hammock BD, Miller MG. 1991. Xenobiotic metabolizing enzyme e activities in rat, mouse, monkey, and human testes. Drug Metab Dispos 19:227-232.
8. Draper AJ, Hammock BD. 1999. Soluble epoxide hydrolase in rat inflammatory cells is indistinguishable from soluble epoxide hydrolase in rat liver. Toxicol Sci 50:30-35.
9. DuTeaux SB, Newmann JW, Morisseau C, Fairbairn EA, Jelks K, Hammock BD, Miller MG. 2004. Epoxide hydrolases in rat epididymus: possible roles in xenobiotic and endogenous fatty acid metabolism. Toxicol Sci 78:187-194.
10. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC. 1990. Dilation of cerebral arterioles by cytochrome P450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 259:H1171-H1177.
11. Enayetallah AE, French RA, Thibodeau MS, Grant DF. 2004. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52:447-454.
12. Enayetallah AE, French RA, Barber M, Grant DF. 2005. Cell specific subcellular localization of soluble epoxide hydrolase in human tissues. J Histochem Cytochem 54:329-335.
13. Enayetallah AE, French RA, Barber M, Grant DF. 2006. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues. J Histochem Cytochem 54:329-335.
14. Ghersi-Egea JF, Leininger-Muller B, Suleman G, Siest G, Minn A. 1994. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62:1089-1096.
15. Gill SS, Ota K, Hammock BD. 1983. Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase. Anal Biochem 131:273-282.
16. Guengerich FP. 2003. Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. Arch Biochem Biophys 409:59-71.
17. Gulick AM, Fahl WE. 1995. Mammalian glutathione s-transferase: regulation of an enzyme system to achieve chemotherapeutic efficacy. Pharmacol Ther 66:237-257.
18. Hammock BD, Ota K. 1983. Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathine S-transferase activities. Toxicol Appl Pharmacol 71:254-265.
19. Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD. 2002. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39:690-694.
20. Jung O, Brandes RP, Kim IH, Schweda F, Schmidt R, Hammock BD, Busse R, Fleming I. 2005. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension. Hypertension 45:759-765.
21. Kessler R, Hamou MF, Albertoni M, Tribolet ND, Arand M, Meir EGV. 2000. Identification of the putative brain tumor antigen BE7/GE2 as the (de) toxifying enzyme microsomal epoxide hydrolase. Cancer Res 60:1403-1409.
22. Koerner IP, Jacks R, DeBarber AE, Koop D, Mao P, Grant DF, Alkayed NJ. 2007. Polymorphism in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. J Neurosci 27:4642-4649.
23. Liu M, Sun A, Shin EJ, Liu X, Kim SG, Runyons CR, Markesbery W, Kim HC, Bing G. 2006. Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous β-amyloid and trimethyl-tin. Eur J Neurosci 23:2027-2034.
24. Lu AY, Miwa GT. 1980. Molecular properties and biological functions of microsomal epoxide hydrolse. Annu Rev Pharmacol Toxicol 20:513-531.
25. Minn A, Ghersi-Egea JF, Perrin R, Leininger B, Siest G. 1991. Drug metabolizing enzyme in the brain and cerebral microvessels. Brain Res Rev 16:65-82.
26. Moody DE, Silva MH, Hammock BD. 1986. Epoxide hydrolysis in the cytosol of rat liver, kidney, and testis. Biochem Pharmacol 35:2073-2080.
27. Morisseau C, Hammock BD. 2005. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45:311-333.
28. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. 1999. Anti-inflammatory properties of cytochrome P450 epooxygenase-derived eicosanoids. Science 285:1276-7279.
29. Pacifici GM, Eriksson LC, Glaumann H, Rane A. 1988. Profile of drug metabolizing enzymes in the nuclear and microsomal fractions from rat liver nodules and normal liver. Arch Toxicol 62:336-340.
30. Paschen W, Frandsen A. 2001. Endoplasmic reticulum dysfunction - a common denominator for cell injury in acute and degenerative diseases of the brain? J Neurochem 79:719-25.
31. Ravindranath V, Bhamre S, Bhagwat SV, Anandatheerthavarada HK, Shankar SK, Tirumalai PS. 1995. Xenobiotic metabolism in brain. Toxicol Lett 82-83:633-638.
32. Schilter B, Omiecinski CJ. 1993. Regional distribution and expression modulation of cytochrome p-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol 44:990-996.
33. Schmeltzer KR, Kubala L, Newman JW, Kim IH, Eiserich, Hammock BD. 2005. Soluble epoxide hydrolase is a therapeutic target for acute Inflammation. Proc Natl Acad Sci U S A 102:9772-9777.
34. Shivachar AC. 2007. Cannabinoid inhibition of sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes. Biochem Pharmacol 73:2004-2011.
35. Shivachar AC, Willoughby KA, Ellis EF. 1995. Effect of protein kinase C modulators on 14,15-epoxyeicosatrienoic acid incorporation into astroglial phospholipids. J Neurochem 65:338-346.
36. Stella L, Pallottini V, Moreno S, Leoni S, DeMaria F, Turella P, Federici G, Fabrini R, Dawood KF, Bello ML, Pedersen JZ, Ricci G. 2007. Electrostatic association of glutathione transferase to the nuclear membrane: evidence of an enzyme defense barrier at the nuclear envelope. J Biol Chem 282:6372-6379.
37. Wixtrom RN, Hammock BD. 1985. Membrane bound and soluble fraction epoxide hydrolases: methodological aspects. In: Zakim D, Vessey DA, editors. Biochemical pharmacology and toxicology, vol 1: methodological aspects of drug metabolizing enzymes. New York: John Wiley & Sons. p 1-93.
38. Zhao X, Yamamoto T, Newman JW, Kim IH, Watanabe T, Hammock BD, Stewart J, Pollock JS, Pollock DM, Imig JD. 1994. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J Am Soc Nephrol 15:1244-1253.